Variant report
Variant | esv3474647 |
---|---|
Chromosome Location | chr6:167195362-167200060 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:167199892..167200482-chr6:167403182..167403715,3 | MCF-7 | breast: | |
2 | chr6:167187491..167191588-chr6:167191761..167196442,4 | K562 | blood: | |
3 | chr6:167198453..167200233-chr6:167409946..167412844,2 | K562 | blood: | |
4 | chr6:167200059..167200966-chr6:167402403..167403438,4 | K562 | blood: | |
5 | chr6:167200031..167200812-chr6:167555407..167555996,2 | K562 | blood: | |
6 | chr6:167187491..167189760-chr6:167193508..167196442,3 | K562 | blood: | |
7 | chr6:167199917..167200852-chr6:167555354..167555927,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000265828 | chromatin interactions |
ENSG00000227598 | chromatin interactions |
ENSG00000213066 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112068878 | chr6:167195382-167195383 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542722424 | chr6:167195414-167195415 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184535742 | chr6:167195473-167195474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371532473 | chr6:167195499-167195500 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529054322 | chr6:167195500-167195501 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550906864 | chr6:167195576-167195577 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569214767 | chr6:167195666-167195667 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533074572 | chr6:167195667-167195668 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35637883 | chr6:167195716-167195717 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187399344 | chr6:167195731-167195732 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs77852948 | chr6:167195770-167195771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs71721078 | chr6:167195771-167195772 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs398072935 | chr6:167195772-167195773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138583354 | chr6:167195773-167195774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373564176 | chr6:167195811-167195812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533901133 | chr6:167195812-167195813 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73788141 | chr6:167195834-167195835 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs567522646 | chr6:167195847-167195848 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538008836 | chr6:167195872-167195873 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs147095612 | chr6:167195877-167195878 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7357046 | chr6:167195911-167195912 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs545352589 | chr6:167196001-167196002 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562397467 | chr6:167196020-167196021 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs845641 | chr6:167196032-167196033 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs191937180 | chr6:167196052-167196053 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs845642 | chr6:167196064-167196065 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs561328361 | chr6:167196077-167196078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374470447 | chr6:167196138-167196139 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184059005 | chr6:167196165-167196166 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs11759767 | chr6:167196188-167196189 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs562522463 | chr6:167196213-167196214 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6415092 | chr6:167196263-167196264 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs77688808 | chr6:167196301-167196302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138263532 | chr6:167196324-167196325 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6456126 | chr6:167196327-167196328 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs149593319 | chr6:167196380-167196381 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs6456127 | chr6:167196403-167196404 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs537542299 | chr6:167196407-167196408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10556799 | chr6:167196413-167196414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs398066496 | chr6:167196419-167196420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs13204401 | chr6:167196499-167196500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549988571 | chr6:167196516-167196517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs11970352 | chr6:167196535-167196536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs371335108 | chr6:167196537-167196538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs71686287 | chr6:167196567-167196568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370184338 | chr6:167196583-167196584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549852227 | chr6:167196661-167196662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554126146 | chr6:167196665-167196666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189955674 | chr6:167196731-167196732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs845643 | chr6:167196776-167196777 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ependymoma | 20639864 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22549408 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:167182200-167218600 | Weak transcription | Right Atrium | heart |
2 | chr6:167195200-167195400 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr6:167195200-167195400 | Enhancers | Brain Inferior Temporal Lobe | brain |
4 | chr6:167195200-167196200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
5 | chr6:167195400-167196200 | Weak transcription | Brain Inferior Temporal Lobe | brain |
6 | chr6:167196200-167196400 | Enhancers | Brain Inferior Temporal Lobe | brain |
7 | chr6:167196400-167198600 | Weak transcription | Brain Inferior Temporal Lobe | brain |
8 | chr6:167196800-167197000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
9 | chr6:167198400-167198800 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
10 | chr6:167198600-167198800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr6:167198600-167198800 | Enhancers | Brain Inferior Temporal Lobe | brain |